NCT07020221 2026-03-09A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsVerastem, Inc.Phase 1/2 Recruiting295 enrolled
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT02675946 2022-01-26CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)Curegenix Inc.Phase 1 Unknown72 enrolled
NCT02981524 2021-02-10Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed17 enrolled 12 charts